Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.

Ebefors K, Wiener RJ, Yu L, Azeloglu EU, Yi Z, Jia F, Zhang W, Baron MH, He JC, Haraldsson B, Daehn I.

Kidney Int. 2019 Oct;96(4):957-970. doi: 10.1016/j.kint.2019.05.007. Epub 2019 May 22.

2.

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.

Schubart A, Anderson K, Mainolfi N, Sellner H, Ehara T, Adams CM, Mac Sweeney A, Liao SM, Crowley M, Littlewood-Evans A, Sarret S, Wieczorek G, Perrot L, Dubost V, Flandre T, Zhang Y, Smith RJH, Risitano AM, Karki RG, Zhang C, Valeur E, Sirockin F, Gerhartz B, Erbel P, Hughes N, Smith TM, Cumin F, Argikar UA, Haraldsson B, Mogi M, Sedrani R, Wiesmann C, Jaffee B, Maibaum J, Flohr S, Harrison R, Eder J.

Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7926-7931. doi: 10.1073/pnas.1820892116. Epub 2019 Mar 29.

3.

Amplification of the Melanocortin-1 Receptor in Nephrotic Syndrome Identifies a Target for Podocyte Cytoskeleton Stabilization.

Bergwall L, Wallentin H, Elvin J, Liu P, Boi R, Sihlbom C, Hayes K, Wright D, Haraldsson B, Nyström J, Buvall L.

Sci Rep. 2018 Oct 24;8(1):15731. doi: 10.1038/s41598-018-34004-7.

4.

Pharmacokinetic Properties of the Nephrotoxin Orellanine in Rats.

Najar D, Haraldsson B, Thorsell A, Sihlbom C, Nyström J, Ebefors K.

Toxins (Basel). 2018 Aug 17;10(8). pii: E333. doi: 10.3390/toxins10080333.

5.

Patients' Perceptions and Factors Affecting Dialysis Modality Decisions.

Friberg IO, Mårtensson L, Haraldsson B, Krantz G, Määttä S, Järbrink K.

Perit Dial Int. 2018 Sep-Oct;38(5):334-342. doi: 10.3747/pdi.2017.00243. Epub 2018 Jul 31.

PMID:
30065063
6.

Treatment Patterns and Survival of Elderly Patients With Breast Cancer Brain Metastases.

Leone JP, Haraldsson B, Mott SL, McDowell BD, Chrischilles EA.

Am J Clin Oncol. 2019 Jan;42(1):60-66. doi: 10.1097/COC.0000000000000477.

PMID:
29965807
7.

Orellanine specifically targets renal clear cell carcinoma.

Buvall L, Hedman H, Khramova A, Najar D, Bergwall L, Ebefors K, Sihlbom C, Lundstam S, Herrmann A, Wallentin H, Roos E, Nilsson UA, Johansson M, Törnell J, Haraldsson B, Nyström J.

Oncotarget. 2017 Jul 25;8(53):91085-91098. doi: 10.18632/oncotarget.19555. eCollection 2017 Oct 31.

8.

Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.

Matuleviciene-Anängen V, Rosengren A, Svensson AM, Pivodic A, Gudbjörnsdottir S, Wedel H, Kosiborod M, Haraldsson B, Lind M.

Heart. 2017 Nov;103(21):1687-1695. doi: 10.1136/heartjnl-2016-311050. Epub 2017 Jul 14.

PMID:
28710186
9.

Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation.

Ammann EM, Drake MT, Haraldsson B, Wallace RB, Johnson KC, Desai P, Lin EM, Link BK.

Cancer. 2017 Nov 1;123(21):4168-4177. doi: 10.1002/cncr.30858. Epub 2017 Jun 27.

10.

Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy.

Liu P, Lassén E, Nair V, Berthier CC, Suguro M, Sihlbom C, Kretzler M, Betsholtz C, Haraldsson B, Ju W, Ebefors K, Nyström J.

J Am Soc Nephrol. 2017 Oct;28(10):2961-2972. doi: 10.1681/ASN.2016101103. Epub 2017 Jun 23.

11.

Long-term clinical outcome for patients poisoned by the fungal nephrotoxin orellanine.

Hedman H, Holmdahl J, Mölne J, Ebefors K, Haraldsson B, Nyström J.

BMC Nephrol. 2017 Apr 3;18(1):121. doi: 10.1186/s12882-017-0533-6.

12.

Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.

Qi H, Casalena G, Shi S, Yu L, Ebefors K, Sun Y, Zhang W, D'Agati V, Schlondorff D, Haraldsson B, Böttinger E, Daehn I.

Diabetes. 2017 Mar;66(3):763-778. doi: 10.2337/db16-0695. Epub 2016 Nov 29.

13.

Perinatal DDT Exposure Induces Hypertension and Cardiac Hypertrophy in Adult Mice.

La Merrill MA, Sethi S, Benard L, Moshier E, Haraldsson B, Buettner C.

Environ Health Perspect. 2016 Nov;124(11):1722-1727. Epub 2016 Jun 21.

14.

Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.

Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J.

BMC Nephrol. 2016 Apr 5;17:40. doi: 10.1186/s12882-016-0251-5.

15.

Treatment pattern in patients with idiopathic membranous nephropathy-practices in Sweden at the start of the millennium.

Lönnbro-Widgren J, Mölne J, Haraldsson B, Nyström J.

Clin Kidney J. 2016 Apr;9(2):227-33. doi: 10.1093/ckj/sfv152. Epub 2016 Jan 27.

16.

The relationship between three eGFR formulas and hospitalization for heart failure in 54 486 individuals with type 2 diabetes.

Tancredi M, Rosengren A, Olsson M, Gudbjörnsdottir S, Svensson AM, Haraldsson B, Lind M.

Diabetes Metab Res Rev. 2016 Oct;32(7):730-735. doi: 10.1002/dmrr.2793. Epub 2016 Apr 28.

PMID:
26888448
17.

Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activation.

Elvin J, Buvall L, Lindskog Jonsson A, Granqvist A, Lassén E, Bergwall L, Nyström J, Haraldsson B.

Am J Physiol Renal Physiol. 2016 May 1;310(9):F846-56. doi: 10.1152/ajprenal.00231.2015. Epub 2016 Feb 17.

18.

Assessing the Accuracy of Continuous Glucose Monitoring (CGM) Calibrated With Capillary Values Using Capillary or Venous Glucose Levels as a Reference.

Andelin M, Kropff J, Matuleviciene V, Joseph JI, Attvall S, Theodorsson E, Hirsch IB, Imberg H, Dahlqvist S, Klonoff D, Haraldsson B, DeVries JH, Lind M.

J Diabetes Sci Technol. 2016 Jun 28;10(4):876-84. doi: 10.1177/1932296815626724. Print 2016 Jul.

19.

Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer Microtumors.

Palm S, Bäck T, Haraldsson B, Jacobsson L, Lindegren S, Albertsson P.

J Nucl Med. 2016 Apr;57(4):594-600. doi: 10.2967/jnumed.115.167825. Epub 2016 Jan 14.

20.

Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy.

Lönnbro-Widgren J, Ebefors K, Mölne J, Nyström J, Haraldsson B.

Clin Kidney J. 2015 Aug;8(4):433-9. doi: 10.1093/ckj/sfv049. Epub 2015 Jul 9.

21.

Decreased eGFR as a Risk Factor for Heart Failure in 13 781 Individuals With Type 1 Diabetes.

Vestberg D, Rosengren A, Olsson M, Gudbjörnsdottir S, Haraldsson B, Svensson AM, Lind M.

J Diabetes Sci Technol. 2015 Jul 31;10(1):131-6. doi: 10.1177/1932296815596174.

22.

[The council for new therapies should immediately revoke their decision on eculizumab].

Karpman D, Fehrman-Ekholm I, Bárány P, Békássy Z, Brandström P, Bruchfeld A, Celsi G, Chromek M, Clyne N, Fellström B, Hansson S, Haraldsson B, Nevéus T, Rippe B, Sartz L, Segelmark M, Stegmayr B, Stenvinkel P, Westman K.

Lakartidningen. 2015 Jun 11;112. pii: DI7D. Swedish. No abstract available.

23.

[The council for new therapies position on eculizumab is unacceptable].

Karpman D, Fehrman-Ekholm I, Bárány P, Békássy Z, Brandström P, Bruchfeld A, Celsi G, Chromek M, Clyne N, Fellström B, Hansson S, Haraldsson B, Nevéus T, Rippe B, Sartz L, Segelmark M, Stegmayr B, Stenvinkel P, Tufveson G, Westman K.

Lakartidningen. 2015 Jun 9;112. pii: DI3F. Swedish. No abstract available.

24.

Urinary albumin excretion in healthy adults: a cross sectional study of 24-hour versus timed overnight samples and impact of GFR and other personal characteristics.

Fagerstrom P, Sallsten G, Akerstrom M, Haraldsson B, Barregard L.

BMC Nephrol. 2015 Jan 24;16:8. doi: 10.1186/1471-2369-16-8.

25.

Predicting the effectiveness of insulin pump therapy on glycemic control in clinical practice: a retrospective study of patients with type 1 diabetes from 10 outpatient diabetes clinics in Sweden over 5 years.

Clements M, Matuleviciene V, Attvall S, Ekelund M, Pivodic A, Dahlqvist S, Fahlén M, Haraldsson B, Lind M.

Diabetes Technol Ther. 2015 Jan;17(1):21-8. doi: 10.1089/dia.2014.0139.

PMID:
25470010
26.

A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes.

Matuleviciene V, Joseph JI, Andelin M, Hirsch IB, Attvall S, Pivodic A, Dahlqvist S, Klonoff D, Haraldsson B, Lind M.

Diabetes Technol Ther. 2014 Nov;16(11):759-67. doi: 10.1089/dia.2014.0238. Epub 2014 Sep 18.

27.

The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial.

Carlsson LM, Romeo S, Jacobson P, Burza MA, Maglio C, Sjöholm K, Svensson PA, Haraldsson B, Peltonen M, Sjöström L.

Int J Obes (Lond). 2015 Jan;39(1):169-75. doi: 10.1038/ijo.2014.72. Epub 2014 May 6.

28.

Rapid increase of interleukin-10 plasma levels after combined auxiliary liver-kidney transplantation in presensitized patients.

Ingelsten M, Gustafsson K, Olausson M, Haraldsson B, Karlsson-Parra A, Nyström J.

Transplantation. 2014 Jul 27;98(2):208-15. doi: 10.1097/TP.0000000000000038.

PMID:
24598935
29.

Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.

Daehn I, Casalena G, Zhang T, Shi S, Fenninger F, Barasch N, Yu L, D'Agati V, Schlondorff D, Kriz W, Haraldsson B, Bottinger EP.

J Clin Invest. 2014 Apr;124(4):1608-21. doi: 10.1172/JCI71195. Epub 2014 Mar 3.

30.

Effects of melanocortin 1 receptor agonists in experimental nephropathies.

Lindskog Jonsson A, Granqvist A, Elvin J, Johansson ME, Haraldsson B, Nyström J.

PLoS One. 2014 Jan 30;9(1):e87816. doi: 10.1371/journal.pone.0087816. eCollection 2014.

31.

The endothelium as part of the integrative glomerular barrier complex.

Haraldsson BS.

Kidney Int. 2014 Jan;85(1):8-11. doi: 10.1038/ki.2013.317.

32.

Zeroing in on the albumin glomerular sieving coefficient.

Haraldsson B, Tanner GA.

Am J Physiol Renal Physiol. 2014 Mar 15;306(6):F577-8. doi: 10.1152/ajprenal.00645.2013. Epub 2013 Dec 26. No abstract available.

33.

A new era of podocyte-targeted therapy for proteinuric kidney disease.

Haraldsson B.

N Engl J Med. 2013 Dec 19;369(25):2453-4. doi: 10.1056/NEJMe1312835. Epub 2013 Nov 8. No abstract available.

PMID:
24206429
34.

A meta-analysis of expression signatures in glomerular disease.

Tryggvason SH, Guo J, Nukui M, Norlin J, Haraldsson B, Jörnvall H, Tryggvason K, He L.

Kidney Int. 2013 Sep;84(3):591-9. doi: 10.1038/ki.2013.169. Epub 2013 Jun 19.

35.

Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx.

Singh A, Ramnath RD, Foster RR, Wylie EC, Fridén V, Dasgupta I, Haraldsson B, Welsh GI, Mathieson PW, Satchell SC.

PLoS One. 2013;8(2):e55852. doi: 10.1371/journal.pone.0055852. Epub 2013 Feb 14.

36.

Modulation of microvascular permeability in the preovulatory rat ovary by an ovulatory gonadotropin stimulus.

Mitsube K, Brännström M, Haraldsson B.

Fertil Steril. 2013 Mar 1;99(3):903-9. doi: 10.1016/j.fertnstert.2012.11.017. Epub 2012 Dec 7.

PMID:
23219013
37.

Analysis of the mushroom nephrotoxin orellanine and its glucosides.

Herrmann A, Hedman H, Rosén J, Jansson D, Haraldsson B, Hellenäs KE.

J Nat Prod. 2012 Oct 26;75(10):1690-6. doi: 10.1021/np300135k. Epub 2012 Oct 9.

PMID:
23046414
38.

Evaluation of effects on the peritoneum after intraperitoneal α-radioimmunotherapy with (211)At.

Cederkrantz E, Angenete E, Bäck T, Falk P, Haraldsson B, Ivarsson ML, Jensen H, Lindegren S, Hultborn R, Jacobsson L.

Cancer Biother Radiopharm. 2012 Aug;27(6):353-64. doi: 10.1089/cbr.2012.1184. Epub 2012 Jun 12.

PMID:
22690847
39.

Hemodiafiltration improves plasma 25-hepcidin levels: a prospective, randomized, blinded, cross-over study comparing hemodialysis and hemodiafiltration.

Stefánsson BV, Abramson M, Nilsson U, Haraldsson B.

Nephron Extra. 2012 Jan;2(1):55-65. doi: 10.1159/000336482. Epub 2012 Mar 28.

40.

The glomerular endothelium: new insights on function and structure.

Haraldsson B, Nyström J.

Curr Opin Nephrol Hypertens. 2012 May;21(3):258-63. doi: 10.1097/MNH.0b013e3283522e7a. Review.

PMID:
22388551
41.

Mechanical properties of human patellar tendon at the hierarchical levels of tendon and fibril.

Svensson RB, Hansen P, Hassenkam T, Haraldsson BT, Aagaard P, Kovanen V, Krogsgaard M, Kjaer M, Magnusson SP.

J Appl Physiol (1985). 2012 Feb;112(3):419-26. doi: 10.1152/japplphysiol.01172.2011. Epub 2011 Nov 23.

42.

[The medical education in Gothenburg is being reformed. Professional development, research and internationalization].

Hanse E, Wahlqvist M, Sturm A, Lindholm C, Haraldsson B, Andersson R, Manhem K.

Lakartidningen. 2011 Mar 23-29;108(12):669-73. Swedish. No abstract available.

PMID:
21534321
43.

Role of glomerular proteoglycans in IgA nephropathy.

Ebefors K, Granqvist A, Ingelsten M, Mölne J, Haraldsson B, Nyström J.

PLoS One. 2011 Apr 6;6(4):e18575. doi: 10.1371/journal.pone.0018575.

44.

Postischemic inflammatory response in an auxiliary liver graft predicts renal graft outcome in sensitized patients.

Ingelsten M, Karlsson-Parra A, Granqvist AB, Mölne J, Olausson M, Haraldsson B, Nyström J.

Transplantation. 2011 Apr 27;91(8):888-94. doi: 10.1097/TP.0b013e3182100f19.

PMID:
21494202
45.

The glomerular endothelial cell coat is essential for glomerular filtration.

Fridén V, Oveland E, Tenstad O, Ebefors K, Nyström J, Nilsson UA, Haraldsson B.

Kidney Int. 2011 Jun;79(12):1322-30. doi: 10.1038/ki.2011.58. Epub 2011 Mar 16.

46.

Acute oxidative stress following intravenous iron injection in patients on chronic hemodialysis: a comparison of iron-sucrose and iron-dextran.

Stefánsson BV, Haraldsson B, Nilsson U.

Nephron Clin Pract. 2011;118(3):c249-56. doi: 10.1159/000321645. Epub 2010 Dec 24.

PMID:
21196770
47.

Dosing of erythropoiesis-stimulating agents can be reduced by a new administration regimen.

Stefánsson BV, Haraldsson B, Nilsson U.

Nephron Extra. 2011 Jan;1(1):45-54. doi: 10.1159/000329889. Epub 2011 Aug 19.

48.

High glucose causes dysfunction of the human glomerular endothelial glycocalyx.

Singh A, Fridén V, Dasgupta I, Foster RR, Welsh GI, Tooke JE, Haraldsson B, Mathieson PW, Satchell SC.

Am J Physiol Renal Physiol. 2011 Jan;300(1):F40-8. doi: 10.1152/ajprenal.00103.2010. Epub 2010 Oct 27.

49.

Tubular reabsorption of albumin: it's all about cubilin.

Haraldsson B.

J Am Soc Nephrol. 2010 Nov;21(11):1810-2. doi: 10.1681/ASN.2010090984. Epub 2010 Oct 14. No abstract available.

50.

Impaired glomerular and tubular antioxidative defense mechanisms in nephrotic syndrome.

Granqvist A, Nilsson UA, Ebefors K, Haraldsson B, Nyström J.

Am J Physiol Renal Physiol. 2010 Oct;299(4):F898-904. doi: 10.1152/ajprenal.00124.2010. Epub 2010 Aug 4.

Supplemental Content

Loading ...
Support Center